Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 9095504 RNA interference in ocular indications
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 4 Sep, 2024
"update inverses"
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12077755 Bioactive conjugates for oligonucleotide delivery
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
0
Edits on 4 Jul, 2024
"update inverses"
Golden AI
edited on 4 Jul, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12024706 Modified oligonucleotides targeting SNPs
0
Edits on 14 Mar, 2024
"update inverses"
Golden AI
edited on 14 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11926828 Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article
(
+105
characters)
Article
Patent abstract
The present invention relates to ocular administration of sd-rxRNA and rxRNAori molecules.
Edits on 27 Sep, 2023
"update inverses"
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11767527 Modified oligonucleotides targeting SNPs
Edits on 13 Sep, 2023
"update inverses"
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11753638 Conjugated oligonucleotides
Edits on 19 Jul, 2023
"update inverses"
Golden AI
edited on 19 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11702659 Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
0
Edits on 14 Jul, 2023
"Remove leading 0 from patent number"
Golden AI
edited on 14 Jul, 2023
Edits made to:
Infobox
(
+1
/
-1
properties)
US Patent 09095504 RNA interference in ocular indications
US Patent 9095504 RNA interference in ocular indications
Infobox
Patent Number
09095504
0
Patent Number
9095504
0
Edits on 26 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 26 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=09095504
0
Edits on 25 Apr, 2023
"Entity importer update"
Golden AI
edited on 25 Apr, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
09095504
0
Date of Patent
August 4, 2015
0
Patent Application Number
13636748
0
Date Filed
March 24, 2011
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=09095504
0
Patent Primary Examiner
Brian Whiteman
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09095504
Edits on 2 Jan, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 2 Jan, 2022
Edits made to:
Infobox
(
+7
properties)
US Patent 09095504 RNA interference in ocular indications
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
09095504
Date of patent
August 4, 2015
Patent application number
13636748
Date Filed
March 24, 2011
Patent primary examiner
Brian Whiteman
Find more entities like US Patent 9095504 RNA interference in ocular indications
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE